|1.||Wang, Sheng: 3 articles (12/2009 - 06/2004)|
|2.||Faller, Douglas V: 3 articles (12/2009 - 06/2004)|
|3.||Zhang, Baohua: 2 articles (12/2009 - 06/2004)|
|4.||Cordaro, F G: 1 article (12/2011)|
|5.||Cosentino, M: 1 article (12/2011)|
|6.||Lombardo, S: 1 article (12/2011)|
|7.||Mjåland, Odd: 1 article (01/2010)|
|8.||Hervik, Jill: 1 article (01/2010)|
|9.||Paller, Channing J: 1 article (03/2009)|
|10.||Dobs, Adrian S: 1 article (03/2009)|
12/01/2009 - "We report here that novel tumor suppressor HIC1 is required for growth suppression by estrogen antagonists in breast cancer cells. "
05/17/1995 - "We also studied the hormonal responsiveness of tumors that became resistant to the two estrogen antagonists and the effects of these drugs on estrogen-regulated gene expression. "
03/01/1992 - "3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity."
11/01/1978 - "Estrogen antagonists are widely used in the treatment of breast cancer, and studies of their mechanism of action may provide clues to an understanding of tumor growth regulation and mechanisms of normal estrogen action. "
10/01/2004 - "Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body."
|2.||Aggressive Fibromatosis (Desmoid)
|3.||Lung Diseases (Lung Disease)
|4.||Female Genital Neoplasms
|5.||Breast Neoplasms (Breast Cancer)
12/01/2009 - "Furthermore, reintroducing HIC1 into resistant breast cancer cells restored their sensitivity to the estrogen antagonists, indicating the existence of a novel regulatory mechanism for growth control of breast cancer cells."
06/02/2004 - "Estrogen antagonists are universally employed in the breast cancer therapy, although antagonist therapy is limited by the inevitable development of cellular resistance. "
01/01/2003 - "Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists."
08/01/1979 - "Daily administration of estrogen antagonists to premenopausal women has been incorporated into the adjuvant treatment of breast cancer. "
01/01/2010 - "The aim of this study was to examine the quality of life of breast cancer patients medicated with estrogen antagonists, 2 years after having acupuncture treatment for hot flashes. "
|5.||Estrogen Receptor Modulators (Antiestrogen)
|6.||Selective Estrogen Receptor Modulators (SERM)